Maharashtra FDA Flags Hospital Consumable Pricing Gap to NPPA
Maharashtra FDA Commissioner Tukaram Munde has recommended action to the NPPA on the pricing gap for hospital consumables, noting patients cannot verify markups.
Maharashtra's Food and Drug Administration Commissioner, Tukaram Munde, has made a recommendation to the National Pharmaceutical Pricing Authority (NPPA) concerning the pricing gap on hospital consumables, pointing to the difficulty patients face in assessing what they are charged for such items during treatment.
Munde observed that a person admitted for care has no means of knowing whether the price listed for a medical consumable matches its actual cost or reflects a markup that was fixed well before the product reached the hospital ward. The gap between the two, he indicated, is central to the concern raised with the national pricing body.
The recommendation places the issue of consumable pricing before the NPPA, the authority responsible for regulating prices of pharmaceuticals and related products. The observation highlights a transparency question for patients, who typically encounter consumable charges as part of a hospital bill without visibility into how those rates are arrived at.
No further details of the recommendation were available in the source material.